E coli production an option for affordable conjugate vaccines
Producing conjugate vaccines in recombinant E coli is potentially simpler and more cost-effective than alternatives, say researchers, but the method suffers from low yields.
Archives for August 17, 2010
Encorium cuts Q2 operating loss despite drop in revenue
Encorium cut its operating loss to $775,000 in the second quarter despite posting a 17 per cent drop in total revenue.
CardioGenics “biologics beads” to change antibody extraction landscape
CardioGenics predicts yield boosting “biologics beads” will change the antibody extraction landscape after signing distribution deal with Merck Chimie.
TRI wins HIV research support contract with US NIAID
TRI has been awarded a contract with the US NIAID to provide clinical, regulatory and operational support for domestic and overseas HIV research.
Imclone closes US Erbitux plant
Imclone has closed the manufacturing facility in Branchburg, New Jersey where it produces the cancer drug Erbitux, according to reports in the US media.